Figure Gallery

Expression Pattern Search Results for mbpa

(191 figures with expression from 110 publications)

[ Show only figures with images ]
Publication	Data	Fish	Condition	Stage Range	Anatomy
Kearns et al., 2015	Fig. 3	WT fbxw7^vu56/vu56 mtor^{xu015Gt/xu015Gt} fbxw7^vu56/vu56; mtor^{xu015Gt/xu015Gt}	standard conditions chemical treatment: sirolimus	Day 4	spinal cord oligodendrocyte whole organism
	Fig. 2	WT mtor^{xu015Gt/xu015Gt}	standard conditions	Day 4	spinal cord oligodendrocyte whole organism
Morris et al., 2015	Fig. 2	WT WT + MO1-mir124-1	standard conditions	Protruding-mouth	oligodendrocyte
Petersen et al., 2015	Fig. 5	WT adgrg6^st63/st63 WT + MO1-lama2 adgrg6^st63/+ adgrg6^st63/+ + MO1-lama2	control standard conditions	Day 4	posterior lateral line myelinating Schwann cell
Pradhan et al., 2015	Fig. S2	WT	standard conditions chemical treatment by environment: 17beta-estradiol	Adult	female organism forebrain female organism hindbrain female organism midbrain male organism forebrain male organism hindbrain male organism midbrain
Sidik et al., 2015	Fig. 1	znf16l^st78/st78 znf16l^st97/st97 znf16l^st78/+ znf16l^st97/+ znf16l^st78/+; znf16l^st97/+	standard conditions	Day 5	central nervous system peripheral nervous system
Yang et al., 2015	Fig. 5	WT dync1h1^vu76/vu76	standard conditions	Day 4	central nervous system myelin sheath
Al Oustah et al., 2014	Fig. 1	WT sulf1^sa199/sa199 sulf1^sa199/+	control standard conditions	Protruding-mouth	spinal cord oligodendrocyte
Blasky et al., 2014	Fig. 6	WT pard3ab^fh305/fh305	standard conditions	Day 4	posterior lateral line nerve trunk nerve
Boczonadi et al., 2014	Fig. 7	WT WT + MO1-exosc8 slc24a5^unspecified	standard conditions standard conditions	5-9 somites to Day 4	lateral line motor neuron axon spinal cord whole organism
	Fig. S3	slc24a5^unspecified slc24a5^unspecified + MO1-exosc8	standard conditions standard conditions	Day 4	head
Fang et al., 2014	Fig. 1	nku1Tg (AB)	standard conditions	Day 4 to Day 6	spinal cord
Huc-Brandt et al., 2014	Fig. 8	ba4Tg ba4Tg + MO4-tp53 + MO5-prnprs3	standard conditions control	Day 5	posterior lateral line myelinating Schwann cell
Laquérriere et al., 2014	Fig. 5	WT WT + MO1-adcy6a + MO1-adcy6b	standard conditions standard conditions	Day 4	central nervous system hindbrain peripheral nervous system posterior lateral line ganglion posterior lateral line nerve spinal cord
Liebscher et al., 2014	Fig. 4	WT adgrg6^st63/st63 adgrg6^{stl215/stl215}	control standard conditions	Day 4 to Day 5	central nervous system posterior lateral line nerve
Lush et al., 2014	Fig. 1	WT	standard conditions control chemical treatment: pharmaceutical	Day 5	myelinating Schwann cell
Mathews et al., 2014	Fig. 2	WT hmgcs1^vu57/vu57 (AB)	standard conditions	Day 4	hindbrain oligodendrocyte spinal cord oligodendrocyte whole organism
	Fig. 4	WT hmgcs1^vu57/vu57 (AB)	control chemical treatment: atorvastatin	Day 4	hindbrain oligodendrocyte whole organism
	Fig. 5	WT hmgcs1^vu57/vu57 (AB)	control chemical treatment: drug chemical treatment: lonafarnib chemical treatment: GGTI-2133	Day 4	hindbrain oligodendrocyte
	Fig. 7	WT hmgcs1^vu57/vu57 (AB)	control chemical treatment: cholesterol chemical treatment: Ro 48-8071	Day 4	hindbrain oligodendrocyte
Paavola et al., 2014	Fig. 5	adgrg6^st86/+	standard conditions	Day 5	lateral line nerve myelinating Schwann cell
Pruvot et al., 2014	Fig. 1	WT WT + MO1-egf	standard conditions control	Day 4	anterior lateral line oligodendrocyte hindbrain medial longitudinal fasciculus midbrain
	Fig. 4	WT	control chemical treatment: pharmaceutical	Day 4	anterior lateral line oligodendrocyte hindbrain medial longitudinal fasciculus midbrain
	Fig. 5	WT	control chemical treatment: pharmaceutical chemical treatment: pharmaceutical chemical treatment: pharmaceutical chemical treatment: pharmaceutical	Day 4	anterior lateral line oligodendrocyte hindbrain medial longitudinal fasciculus midbrain
Smith et al., 2014	Fig. 7	AB	standard conditions	Day 4	ventral root